Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2016 1
2020 1
2021 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Treating Hyperphosphatemia With Lanthanum Carbonate vs Calcium Carbonate on Cardiovascular Events in Patients With Chronic Kidney Disease Undergoing Hemodialysis: The LANDMARK Randomized Clinical Trial.
Ogata H, Fukagawa M, Hirakata H, Kagimura T, Fukushima M, Akizawa T; LANDMARK Investigators and Committees. Ogata H, et al. JAMA. 2021 May 18;325(19):1946-1954. doi: 10.1001/jama.2021.4807. JAMA. 2021. PMID: 34003226 Free PMC article. Clinical Trial.
Treatment of patients with COVID-19 on hemodialysis: Efficacy of remdesivir.
Nakaya A, Kondo M, Ogura E, Katayama Y, Yoshino E, Hozumi K, Tago S, Teranishi Y, Minamibashi Y, Harada M, Kawano Y, Arai Y, Kobayashi M, Kouyama A, Yoshida K, Shimizu S, Ogura K, Iwashita K; BOH Covid-19 Team. Nakaya A, et al. Among authors: kondo m. Nefrologia (Engl Ed). 2023 Dec;43 Suppl 2:112-113. doi: 10.1016/j.nefroe.2022.07.008. Epub 2023 Jan 25. Nefrologia (Engl Ed). 2023. PMID: 36707332 Free PMC article. No abstract available.
[Treatment of patients with COVID-19 on Hemodialysis: Efficacy of Remdesivir].
Nakaya A, Kondo M, Ogura E, Katayama Y, Yoshino E, Hozumi K, Tago S, Teranishi Y, Minamibashi Y, Harada M, Kawano Y, Arai Y, Kobayashi M, Kouyama A, Yoshida K, Shimizu S, Ogura K, Iwashita K; BOH Covid-19 Team. Nakaya A, et al. Among authors: kondo m. Nefrologia. 2022 Aug 3. doi: 10.1016/j.nefro.2022.07.004. Online ahead of print. Nefrologia. 2022. PMID: 35937587 Free PMC article.
Annual Iron Loss Associated with Hemodialysis.
Tsukamoto T, Matsubara T, Akashi Y, Kondo M, Yanagita M. Tsukamoto T, et al. Among authors: kondo m. Am J Nephrol. 2016;43(1):32-8. doi: 10.1159/000444335. Epub 2016 Feb 18. Am J Nephrol. 2016. PMID: 26885949
Anti-pruritic effect of nemolizumab in hemodialysis patients with uremic pruritus: a phase II, randomized, double-blind, placebo-controlled clinical study.
Kinugasa E, Igawa K, Shimada H, Kondo M, Funakoshi S, Imada N, Itami N, Fukazawa N, Takubo R, Kawata Y, Murota H. Kinugasa E, et al. Among authors: kondo m. Clin Exp Nephrol. 2021 Aug;25(8):875-884. doi: 10.1007/s10157-021-02047-2. Epub 2021 Mar 22. Clin Exp Nephrol. 2021. PMID: 33754202 Free PMC article. Clinical Trial.
Efficacy and tolerability of vildagliptin in type 2 diabetic patients on hemodialysis.
Kume S, Uzu T, Takagi C, Kondo M, Okabe T, Araki S, Isshiki K, Takeda N, Kondo K, Haneda M, Koya D, Nishio Y, Kashiwagi A, Maegawa H. Kume S, et al. Among authors: kondo m. J Diabetes Investig. 2012 Jun 6;3(3):298-301. doi: 10.1111/j.2040-1124.2011.00169.x. J Diabetes Investig. 2012. PMID: 24843580 Free PMC article.